• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Digital Mental Health Company Meru Snags $8.1M in Series A Funds

Share:

May 18, 2020

Digital mental health company Meru Health announced that it scored $8.1 million in Series A funding. Foundry Group, Slack, Bold Capital, and Y Combinator led the funding round. This comes about a year after the company landed $4.2 million in seed funding.

Yesterday Meru Health also announced the results of its study, which was done with Harvard Medical School and Rutgers University researchers, on the “Feasibility and Efficacy of the Addition of Heart Rate Variability Biofeedback to a Remote Digital Health Intervention for Depression,” which was published in Springer Link. The study found that Meru’s biofeedback system significantly helped reduce depression symptoms.

WHAT THEY DO

Meru Health offers several different services, including a 12-week tailored content program. Each week has a different theme that builds on the previous one.

In addition to the program, users have access to therapists, whom they can reach out to during the 12-week program. Users also have access to anonymous peer support groups. The program targets people dealing with depression, burnout and anxiety.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The platform also lets customers book a session with a Meru Therapist and get connected in minutes.

Its most recent addition, is a biofeedback system. The tool includes a small device that is clipped on a user’s ear when they are doing a specific biofeedback practice provided by the Meru platform. Users will then get feedback about their heart rate variability during the session. The idea is to help participants see results and train their breathing practices.

WHAT IT’S FOR

While the company did not specify exactly how the funds will be used, it has been stressing its commitment to furthering research on its product and digital mental health.

“​The timing of this funding and publication of our exceptional clinical results couldn’t be better,”​ said Kristian Ranta, Meru Health Founder and CEO. ​“With the recent COVID-19 Crisis, we are seeing a surge in demand as well as the loosening of barriers to make telehealth and remote care more accessible. We are excited to be working with several large health insurance companies and employers to make Meru’s best-in-class care available for people in need. I’m extremely proud of our team and honored to work with such great commercial and research partners.”

MARKET SNAPSHOT

Digital mental health tools are plentiful on the market. In 2020 alone, the investment dollars in the space are adding up. Direct-to-consumer meditation company Headspace scored a whopping $53 million in Series C funding. Employer-focused mental health startup Modern Health took home $31 million in Series B funding in January. Digital mental health tracker Unmind raked in $10.5 million in Series A funds.

Source: MobiHealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Infermedica Launches Ai Feature to Connect Patients with SpecialistsInfermedica Launches Ai Feature to Connect Patients with Specialists
  • CHG Healthcare Acquires Physician Credentialing Company Modio HealthCHG Healthcare Acquires Physician Credentialing Company Modio Health
  • Gemphire Flirts With $1 Level As Struggling Biotech Strikes Reverse Merger DealGemphire Flirts With $1 Level As Struggling Biotech Strikes Reverse Merger Deal
  • Abbott’s Device-Controlled Deep Brain Stimulation System Receives Expanded Indication for Parkinson’s TreatmentAbbott’s Device-Controlled Deep Brain Stimulation System Receives Expanded Indication for Parkinson’s Treatment
  • Boehringer Ingelheim Signs Option to Acquire Trutino BiosciencesBoehringer Ingelheim Signs Option to Acquire Trutino Biosciences
  • Cognoa Teams up with Autism Learning Partners; Meditation.live Available on Slack Marketplace and More Digital Health DealsCognoa Teams up with Autism Learning Partners; Meditation.live Available on Slack Marketplace and More Digital Health Deals
  • How digital therapeutic company Omada Health has taken a cue from life sciencesHow digital therapeutic company Omada Health has taken a cue from life sciences
  • Fitbit Just Announced Its New Apple Watch Competitor That Comes With Amazon AlexaFitbit Just Announced Its New Apple Watch Competitor That Comes With Amazon Alexa

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications